Animal models of age-related macular degeneration and their translatability into the clinic

References

• Global data on visual impairments. WHO. Geneva, Switzerland, 2012. Available from: www.iapb.org/sites/iapb.org/files/GLOBALDATAFINALforweb.pdf [Last accessed 25 March 2014]
   Google Scholar
• Ardeljan D, Chan CC. Aging is not a disease: distinguishing age-related macular degeneration from aging. Prog Retin Eye Res 2013;37:68-89
   PubMed Web of Science ®Google Scholar
• Coleman HR, Chan CC, Ferris FL 3rd, Chew EY. Age-related macular degeneration. Lancet 2008;372(9652):1835-45
   PubMed Web of Science ®Google Scholar
• Telander DG. Inflammation and age-related macular degeneration (AMD). Semin Ophthalmol 2011;26(3):192-7
   PubMed Web of Science ®Google Scholar
• Wang L, Clark ME, Crossman DK, et al. Abundant lipid and protein components of drusen. PLoS One 2010;5(4):e10329
   Web of Science ®Google Scholar
• Doyle SL, Campbell M, Ozaki E, et al. NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat Med 2012;18(5):791-8
   PubMed Web of Science ®Google Scholar
• Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. N Engl J Med 2008;358(24):2606-17
   PubMed Web of Science ®Google Scholar
• Fritsche LG, Chen W, Schu M, et al. Seven new loci associated with age-related macular degeneration. Nat Genet 2013;45(4):433-9; 39e1-2
   PubMed Web of Science ®Google Scholar
• Seddon JM, Cote J, Page WF, et al. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 2005;123(3):321-7
   PubMed Web of Science ®Google Scholar
• Chen Y, Bedell M, Zhang K. Age-related macular degeneration: genetic and environmental factors of disease. Mol Interv 2010;10(5):271-81
   PubMedGoogle Scholar
• Ni Dhubhghaill SS, Cahill MT, Campbell M, et al. The pathophysiology of cigarette smoking and age-related macular degeneration. Adv Exp Med Biol 2010;664:437-46
   PubMed Web of Science ®Google Scholar
• Swaroop A, Chew EY, Rickman CB, Abecasis GR. Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu Rev Genomics Hum Genet 2009;10:19-43
   PubMed Web of Science ®Google Scholar
• Pennesi ME, Neuringer M, Courtney RJ. Animal models of age related macular degeneration. Mol Aspects Med 2012;33(4):487-509
   PubMed Web of Science ®Google Scholar
• Ramkumar HL, Zhang J, Chan CC. Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD). Prog Retin Eye Res 2010;29(3):169-90
   PubMed Web of Science ®Google Scholar
• Ambati J, Anand A, Fernandez S, et al. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med 2003;9(11):1390-7
   PubMed Web of Science ®Google Scholar
• Tuo J, Bojanowski CM, Zhou M, et al. Murine Ccl2/Cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. Invest Ophthalmol Vis Sci 2007;48(8):3827-36
   PubMed Web of Science ®Google Scholar
• Coffey PJ, Gias C, McDermott CJ, et al. Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc Natl Acad Sci USA 2007;104(42):16651-6
   PubMed Web of Science ®Google Scholar
• Ufret-Vincenty RL, Aredo B, Liu X, et al. Transgenic mice expressing variants of complement factor H develop AMD-like retinal findings. Invest Ophthalmol Vis Sci 2010;51(11):5878-87
   PubMed Web of Science ®Google Scholar
• Imamura Y, Noda S, Hashizume K, et al. Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc Natl Acad Sci USA 2006;103(30):11282-7
   PubMed Web of Science ®Google Scholar
• Justilien V, Pang JJ, Renganathan K, et al. SOD2 knockdown mouse model of early AMD. Invest Ophthalmol Vis Sci 2007;48(10):4407-20
   PubMed Web of Science ®Google Scholar
• Hahn P, Qian Y, Dentchev T, et al. Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc Natl Acad Sci USA 2004;101(38):13850-5
   PubMed Web of Science ®Google Scholar
• Dithmar S, Curcio CA, Le NA, et al. Ultrastructural changes in Bruch’s membrane of apolipoprotein E-deficient mice. Invest Ophthalmol Vis Sci 2000;41(8):2035-42
   PubMed Web of Science ®Google Scholar
• Kliffen M, Lutgens E, Daemen MJ, et al. The APO(*)E3-Leiden mouse as an animal model for basal laminar deposit. Br J Ophthalmol 2000;84(12):1415-19
   PubMed Web of Science ®Google Scholar
• Malek G, Johnson LV, Mace BE, et al. Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. Proc Natl Acad Sci USA 2005;102(33):11900-5
   PubMed Web of Science ®Google Scholar
• Liu B, Wei L, Meyerle C, et al. Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. J Transl Med 2011;9:1-12
   PubMed Web of Science ®Google Scholar
• Wei L, Liu B, Tuo J, et al. Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. Cell Rep 2012;2(5):1151-8
   PubMed Web of Science ®Google Scholar
• Ardeljan D, Wang Y, Park S, et al. Interleukin-17 retinotoxicity is prevented by gene transfer of a soluble interleukin-17 receptor acting as a cytokine blocker: implications for age-related macular degeneration. PLoS One 2014;9(4):e95900
   PubMed Web of Science ®Google Scholar
• Dridi S, Hirano Y, Tarallo V, et al. ERK1/2 activation is a therapeutic target in age-related macular degeneration. Proc Natl Acad Sci USA 2012;109(34):13781-6
   PubMed Web of Science ®Google Scholar
• Williams JA, Greenwood J, Moss SE. Retinal changes precede visual dysfunction in the complement factor H knockout mouse. PLoS One 2013;8(7):e68616
   PubMed Web of Science ®Google Scholar
• Tarallo V, Hirano Y, Gelfand BD, et al. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 2012;149(4):847-59
   PubMed Web of Science ®Google Scholar
• Marneros AG. NLRP3 inflammasome blockade inhibits VEGF-A-induced age-related macular degeneration. Cell Rep 2013;4(5):945-58
   PubMed Web of Science ®Google Scholar
• Zhao Z, Chen Y, Wang J, et al. Age-related retinopathy in NRF2-deficient mice. PLoS One 2011;6(4):e19456
   PubMed Web of Science ®Google Scholar
• Hadziahmetovic M, Dentchev T, Song Y, et al. Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD. Invest Ophthalmol Vis Sci 2008;49(6):2728-36
   PubMed Web of Science ®Google Scholar
• Tanaka N, Ikawa M, Mata NL, Verma IM. Choroidal neovascularization in transgenic mice expressing prokineticin 1: an animal model for age-related macular degeneration. Mol Ther 2006;13(3):609-16
   PubMed Web of Science ®Google Scholar
• Heckenlively JR, Hawes NL, Friedlander M, et al. Mouse model of subretinal neovascularization with choroidal anastomosis. Retina 2003;23(4):518-22
   PubMed Web of Science ®Google Scholar
• Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 2013;309(19):2005-15
   PubMed Web of Science ®Google Scholar
• Chew EY, Clemons TE, Sangiovanni JP, et al. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. JAMA Ophthalmol 2014;132(2):142-9
   PubMed Web of Science ®Google Scholar
• Ramkumar HL, Tuo J, Shen D, et al. Nutrient supplementation with n3 polyunsaturated fatty acids, lutein, and zeaxanthin decrease A2E accumulation and VEGF Expression in the retinas of Ccl2/Cx3cr1-deficient mice on Crb1rd8 background. J Nutr 2013;143(7):1129-35
   PubMed Web of Science ®Google Scholar
• Tuo J, Ross RJ, Herzlich AA, et al. A high omega-3 fatty acid diet reduces retinal lesions in a murine model of macular degeneration. Am J Pathol 2009;175(2):799-807
   PubMed Web of Science ®Google Scholar
• Jones A, Kumar S, Zhang N, et al. Increased expression of multifunctional serine protease, HTRA1, in retinal pigment epithelium induces polypoidal choroidal vasculopathy in mice. Proc Natl Acad Sci USA 2011;108(35):14578-83
   PubMed Web of Science ®Google Scholar
• Yannuzzi LA, Sorenson J, Spaide RF, Lipson B. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 1990;10(1):1-8
   PubMed Web of Science ®Google Scholar
• Kumar S, Berriochoa Z, Ambati BK, Fu Y. Angiographic features of transgenic mice with increased expression of human serine protease HTRA1 in retinal pigment epithelium. Invest Ophthalmol Vis Sci 2014;55(6):3842-50
   PubMed Web of Science ®Google Scholar
• McGonigle P, Ruggeri B. Animal models of human disease: challenges in enabling translation. Biochem Pharmacol 2014;87(1):162-71
   PubMed Web of Science ®Google Scholar
• Albright CD, Zeisel SH, Salganik RI. Choline deficiency induces apoptosis and decreases the number of eosinophilic preneoplastic foci in the liver of OXYS rats. Pathobiology 1998;66(2):71-6
   PubMed Web of Science ®Google Scholar
• Markovets AM, Saprunova VB, Zhdankina AA, et al. Alterations of retinal pigment epithelium cause AMD-like retinopathy in senescence-accelerated OXYS rats. Aging (Albany NY) 2011;3(1):44-54
   PubMedGoogle Scholar
• Kozhevnikova OS, Korbolina EE, Stefanova NA, et al. Association of AMD-like retinopathy development with an Alzheimer’s disease metabolic pathway in OXYS rats. Biogerontology 2013;14(6):753-62
   PubMed Web of Science ®Google Scholar
• Lukiw WJ, Surjyadipta B, Dua P, Alexandrov PN. Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer’s disease (AD) and in age-related macular degeneration (AMD). Int J Biochem Mol Biol 2012;3(1):105-16
   PubMedGoogle Scholar
• Markovets AM, Fursova AZ, Kolosova NG. Therapeutic action of the mitochondria-targeted antioxidant SkQ1 on retinopathy in OXYS rats linked with improvement of VEGF and PEDF gene expression. PLoS One 2011;6(7):e21682
   Web of Science ®Google Scholar
• Grossniklaus HE, Kang SJ, Berglin L. Animal models of choroidal and retinal neovascularization. Prog Retin Eye Res 2010;29(6):500-19
   PubMed Web of Science ®Google Scholar
• Davis BM, Normando EM, Guo L, et al. Topical delivery of Avastin to the posterior segment of the eye in vivo using annexin A5-associated liposomes. Small 2014;10(8):1575-84
   PubMed Web of Science ®Google Scholar
• Singh SR, Grossniklaus HE, Kang SJ, et al. Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV. Gene Ther 2009;16(5):645-59
   PubMed Web of Science ®Google Scholar
• Hyvarinen L. Vascular structures of the rabbit retina. Acta Ophthalmol (Copenh) 1967;45(6):852-61
   PubMed Web of Science ®Google Scholar
• elDirini AA, Ogden TE, Ryan SJ. Subretinal endophotocoagulation: a new model of subretinal neovascularization in the rabbit. Retina 1991;11(2):244-9
   PubMed Web of Science ®Google Scholar
• Wong CG, Rich KA, Liaw LH, et al. Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit. Curr Eye Res 2001;22(2):140-7
   PubMed Web of Science ®Google Scholar
• Qiu G, Stewart JM, Sadda S, et al. A new model of experimental subretinal neovascularization in the rabbit. Exp Eye Res 2006;83(1):141-52
   PubMed Web of Science ®Google Scholar
• Julien S, Kreppel F, Beck S, et al. A reproducible and quantifiable model of choroidal neovascularization induced by VEGF A165 after subretinal adenoviral gene transfer in the rabbit. Mol Vis 2008;14:1358-72
   PubMed Web of Science ®Google Scholar
• Ni M, Holland M, Jarstadmarken H, De Vries G. Time-course of experimental choroidal neovascularization in Dutch-Belted rabbit: clinical and histological evaluation. Exp Eye Res 2005;81(3):286-97
   PubMed Web of Science ®Google Scholar
• Peden MC, Min J, Meyers C, et al. Ab-externo AAV-mediated gene delivery to the suprachoroidal space using a 250 micron flexible microcatheter. PLoS One 2011;6(2):e17140
   PubMed Web of Science ®Google Scholar
• Zahn G, Vossmeyer D, Stragies R, et al. Preclinical evaluation of the novel small-molecule integrin alpha5beta1 inhibitor JSM6427 in monkey and rabbit models of choroidal neovascularization. Arch Ophthalmol 2009;127(10):1329-35
   PubMedGoogle Scholar
• Falkenstein IA, Cheng L, Wong-Staal F, et al. Toxicity and intraocular properties of a novel long-acting anti-proliferative and anti-angiogenic compound IMS2186. Curr Eye Res 2008;33(7):599-609
   PubMed Web of Science ®Google Scholar
• Yasukawa T, Kimura H, Tabata Y, et al. Targeted delivery of anti-angiogenic agent TNP-470 using water-soluble polymer in the treatment of choroidal neovascularization. Invest Ophthalmol Vis Sci 1999;40(11):2690-6
   PubMed Web of Science ®Google Scholar
• Yasukawa T, Kimura H, Tabata Y, et al. Targeting of interferon to choroidal neovascularization by use of dextran and metal coordination. Invest Ophthalmol Vis Sci 2002;43(3):842-8
   PubMed Web of Science ®Google Scholar
• Robinson MR, Baffi J, Yuan P, et al. Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization. Exp Eye Res 2002;74(2):309-17
   PubMed Web of Science ®Google Scholar
• Berdugo M, Bejjani RA, Valamanesh F, et al. Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes. Invest Ophthalmol Vis Sci 2008;49(4):1633-44
   PubMed Web of Science ®Google Scholar
• Bertschinger DR, Beknazar E, Simonutti M, et al. A review of in vivo animal studies in retinal prosthesis research. Graefes Arch Clin Exp Ophthalmol 2008;246(11):1505-17
   PubMed Web of Science ®Google Scholar
• Sanchez I, Martin R, Ussa F, Fernandez-Bueno I. The parameters of the porcine eyeball. Graefes Arch Clin Exp Ophthalmol 2011;249(4):475-82
   PubMed Web of Science ®Google Scholar
• Saishin Y, Silva RL, Saishin Y, et al. Periocular injection of microspheres containing PKC412 inhibits choroidal neovascularization in a porcine model. Invest Ophthalmol Vis Sci 2003;44(11):4989-93
   PubMed Web of Science ®Google Scholar
• Kiilgaard JF, Andersen MV, Wiencke AK, et al. A new animal model of choroidal neovascularization. Acta Ophthalmol Scand 2005;83(6):697-704
   PubMedGoogle Scholar
• Lassota N, Kiilgaard JF, Prause JU, et al. Surgical induction of choroidal neovascularization in a porcine model. Graefes Arch Clin Exp Ophthalmol 2007;245(8):1189-98
   PubMed Web of Science ®Google Scholar
• Lassota N, Kiilgaard JF, la Cour M, et al. Natural history of choroidal neovascularization after surgical induction in an animal model. Acta Ophthalmol 2008;86(5):495-503
   PubMed Web of Science ®Google Scholar
• Lassota N, Prause JU, Scherfig E, et al. Clinical and histological findings after intravitreal injection of bevacizumab (Avastin) in a porcine model of choroidal neovascularization. Acta Ophthalmol 2010;88(3):300-8
   PubMed Web of Science ®Google Scholar
• Saishin Y, Silva RL, Saishin Y, et al. Periocular gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization in a human-sized eye. Hum Gene Ther 2005;16(4):473-8
   PubMed Web of Science ®Google Scholar
• Maugeri A, Meire F, Hoyng CB, et al. A novel mutation in the ELOVL4 gene causes autosomal dominant Stargardt-like macular dystrophy. Invest Ophthalmol Vis Sci 2004;45(12):4263-7
   PubMed Web of Science ®Google Scholar
• Sommer JR, Estrada JL, Collins EB, et al. Production of ELOVL4 transgenic pigs: a large animal model for Stargardt-like macular degeneration. Br J Ophthalmol 2011;95(12):1749-54
   PubMed Web of Science ®Google Scholar
• Zhang K, Kniazeva M, Han M, et al. A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat Genet 2001;27(1):89-93
   PubMed Web of Science ®Google Scholar
• Karan G, Lillo C, Yang Z, et al. Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: a model for macular degeneration. Proc Natl Acad Sci USA 2005;102(11):4164-9
   PubMed Web of Science ®Google Scholar
• Stafford TJ, Anness SH, Fine BS. Spontaneous degenerative maculopathy in the monkey. Ophthalmology 1984;91(5):513-21
   PubMed Web of Science ®Google Scholar
• Umeda S, Ayyagari R, Allikmets R, et al. Early-onset macular degeneration with drusen in a cynomolgus monkey (Macaca fascicularis) pedigree: exclusion of 13 candidate genes and loci. Invest Ophthalmol Vis Sci 2005;46(2):683-91
   PubMed Web of Science ®Google Scholar
• Gouras P, Ivert L, Mattison JA, et al. Drusenoid maculopathy in rhesus monkeys: autofluorescence, lipofuscin and drusen pathogenesis. Graefes Arch Clin Exp Ophthalmol 2008;246(10):1403-11
   PubMed Web of Science ®Google Scholar
• Gouras P, Ivert L, Landauer N, et al. Drusenoid maculopathy in rhesus monkeys (Macaca mulatta): effects of age and gender. Graefes Arch Clin Exp Ophthalmol 2008;246(10):1395-402
   PubMed Web of Science ®Google Scholar
• Umeda S, Suzuki MT, Okamoto H, et al. Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis). FASEB J 2005;19(12):1683-5
   PubMedGoogle Scholar
• Francis PJ, Appukuttan B, Simmons E, et al. Rhesus monkeys and humans share common susceptibility genes for age-related macular disease. Hum Mol Genet 2008;17(17):2673-80
   PubMed Web of Science ®Google Scholar
• Singh KK, Krawczak M, Dawson WW, Schmidtke J. Association of HTRA1 and ARMS2 gene variation with drusen formation in rhesus macaques. Exp Eye Res 2009;88(3):479-82
   PubMed Web of Science ®Google Scholar
• Ryan SJ. The development of an experimental model of subretinal neovascularization in disciform macular degeneration. Trans Am Ophthalmol Soc 1979;77:707-45
   PubMedGoogle Scholar
• Miller JW, Adamis AP, Shima DT, et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 1994;145(3):574-84
   PubMed Web of Science ®Google Scholar
• Shen WY, Lee SY, Yeo I, et al. Predilection of the macular region to high incidence of choroidal neovascularization after intense laser photocoagulation in the monkey. Arch Ophthalmol 2004;122(3):353-60
   PubMedGoogle Scholar
• Criswell MH, Ciulla TA, Hill TE, et al. The squirrel monkey: characterization of a new-world primate model of experimental choroidal neovascularization and comparison with the macaque. Invest Ophthalmol Vis Sci 2004;45(2):625-34
   PubMed Web of Science ®Google Scholar
• Husain D, Kim I, Gauthier D, et al. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey. Arch Ophthalmol 2005;123(4):509-16
   PubMed Web of Science ®Google Scholar
• Lichtlen P, Lam TT, Nork TM, et al. Relative contribution of VEGF and TNF-alpha in the cynomolgus laser-induced CNV model: comparing the efficacy of bevacizumab, adalimumab, and ESBA105. Invest Ophthalmol Vis Sci 2010;51(9):4738-45
   PubMed Web of Science ®Google Scholar
• Shen WY, Garrett KL, Wang CG, et al. Preclinical evaluation of a phosphorothioate oligonucleotide in the retina of rhesus monkey. Lab Invest 2002;82(2):167-82
   PubMed Web of Science ®Google Scholar
• Koh HJ, Freeman WR, Azen SP, et al. Effect of a novel octapeptide urokinase fragment, A6, on experimental choroidal neovascularization in the monkey. Retina 2006;26(2):202-9
   PubMed Web of Science ®Google Scholar
• Lai CM, Shen WY, Brankov M, et al. Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys. Mol Ther 2005;12(4):659-68
   PubMed Web of Science ®Google Scholar
• Kim IK, Husain D, Michaud N, et al. Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid. Invest Ophthalmol Vis Sci 2006;47(1):357-63
   PubMed Web of Science ®Google Scholar
• Miller JW, Walsh AW, Kramer M, et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol 1995;113(6):810-18
   PubMed Web of Science ®Google Scholar
• Malinow MR, Feeney-Burns L, Peterson LH, et al. Diet-related macular anomalies in monkeys. Invest Ophthalmol Vis Sci 1980;19(8):857-63
   PubMed Web of Science ®Google Scholar
• Gottfredsdottir MS, Sverrisson T, Musch DC, Stefansson E. Age related macular degeneration in monozygotic twins and their spouses in Iceland. Acta Ophthalmol Scand 1999;77(4):422-5
   PubMedGoogle Scholar
• Kaneko H, Dridi S, Tarallo V, et al. DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature 2011;471(7338):325-30
   PubMed Web of Science ®Google Scholar
• Oliver VF, Franchina M, Jaffe AE, et al. Hypomethylation of the IL17RC promoter in peripheral blood leukocytes is not a hallmark of age-related macular degeneration. Cell Rep 2013;5(6):1527-35
   PubMed Web of Science ®Google Scholar